ATC/DDD

ATC/DDD index J01XD

You are here: Home > ATC/DDD > J > J01 > J01X

- ATC/DDD
Anatomical therapeutic chemical (ATC) classification system
- J
ANTIINFECTIVES FOR SYSTEMIC USE
- J01
ANTIBACTERIALS FOR SYSTEMIC USE
- J01X
OTHER ANTIBACTERIALS

J01XD

Imidazole derivatives

ATC/DDD code J01XD for Imidazole derivatives

This group comprises imidazole antibacterials acting through active metabolites in anaerobic bacteria. Only formulations for parenteral use of e.g. metronidazole are classified in this group. Oral formulations and suppositories of imidazole derivatives are classified in P01 -

Antiprotozoals. Pessaries are classified in G01 - Gynecological antiinfectives and antiseptics.

The DDDs for the parenteral imidazole formulations are based on the treatment of anaerobic bacteria infections.

J01XD01
Metronidazole
J01XD02
Tinidazole
J01XD03
Ornidazole
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us